
Jesús Merayo Lloves
Doctor en Medicina y Cirugía
Cursos que imparte
-
- Eduardo Anitua
- Aintzane Torre
- Mohammad H. Alkhraisat
- Borja de la Sen Corcuera
- Francisco Muruzabal del Castillo
- Sabino Padilla
- Laura Piñas
- Ricardo Tejero
- Ramón Cugat
- Mikel Sánchez Álvarez
- Francisco Angulo Rivera
- Bruno Ardanza Trevijano
- Juan Azofra
- Ana Ballester Torregrosa
- Nicolás Fiz Sánchez
- Yosu Franco Iriarte
- Víctor Galán
- Ander García Etxeberria
- Cristina García Millán
- Ane Garmendia Madariaga
- Xavier Gasol Santa
- Jorge Guadilla Aisuaga
- Natalia Jiménez Gómez
- Álex Martínez
- Jesús Merayo Lloves
- Jaime Oraa Apraiz
- Ana Cristina Riestra
- Francisco Rodríguez Cuadrado
- Alberto Sánchez
- Ronald Sánchez Ávila
- Roberto Seijas Vázquez
- Víctor Vaquerizo
- Fernando Yangüela Rodilla
- Abraham Zavala García
Experto en Terapias Biológicas Aplicadas a la Medicina Regenerativa [2026-2027]
06/11/2026Mixto
Artículos publicados
- Autor:
- Jesús Merayo Lloves
- Berisa-Prado S
- Vázquez N
- Chacón M
- Persinal-Medina M
- Alonso-Alonso S
- Baamonde B
- Alfonso JF
- Fernández-Vega-Cueto L
- Meana Á.
Mini Cleanroom for the Manufacture of Advanced Therapy Medicinal Products (ATMP): Bioengineered Corneal Epithelium
Pharmaceutics. 2021 Aug 17;13(8):1282. Among several requirements for the manufacture of Advanced Therapy Medicinal Products (ATMP) are: following the guidelines of a pharmaceutical quality system, complying with Good Manufacturing Practice (GMP) and access to a cleanroom fulfilling strict environmental conditions (Class A work area and Class B environment). This makes ATMP expensive.
- Autor:
- Eduardo Anitua
- Francisco Muruzabal del Castillo
- Gorka Orive
- Jesús Merayo Lloves
- Ronald Sánchez Ávila
- Fernández ML
- Rodríguez-Gutiérrez LA
- Rodríguez-Calvo PP
- Fernández-Vega Cueto A
Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma
Int Med Case Rep J. 2018 May 1;11:97-103. To evaluate the efficacy and safety of plasma rich in growth factors (PRGF) eye drops in patients with glaucoma with secondary ocular surface disorders (OSDs) due to surgeries and topical hypotensive drugs use.
- Autor:
- Eduardo Anitua
- Francisco Muruzabal del Castillo
- Gorka Orive
- Jesús Merayo Lloves
- Ana Cristina Riestra
- Sanchez-Avila RM
- Berisa S
- Lisa C
- Sánchez JA
Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders
Medicine (Baltimore). 2018 Apr;97(17):e0242. To evaluate the safety and efficacy of the surgical use of plasma rich in growth factors fibrin membrane (mPRGF) in different ocular surface pathologies.Fifteen patients with different corneal and conjunctival diseases were included in the study. Patients were grouped according to the use of mPRGF as graft (corneal and/or conjunctival) or dressing; they were also grouped according to the surgical subgroup of intervention (persistent corneal ulcer [PCU], keratoplasty, superficial keratectomy, corneal perforation, and pterygium).
- Autor:
- Eduardo Anitua
- Gorka Orive
- Jesús Merayo Lloves
- Ana Cristina Riestra
- Vazquez N
- Chacon M
- Berisa S
- Sanchez-Avila RM
- Meana A
Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology
Ocul Surf. 2017 Apr;15(2):248-256. Develop an autologous culture method for ex vivo expansion of human limbal epithelial progenitor cells (LEPCs) using Plasma Rich in Growth Factors (PRGF) as a growth supplement and as a scaffold for the culture of LEPCs.

English
Français
Deutsch
Italiano
Português